Position in AMGN
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$917,249
+$26,013 QoQ
Shares Held
2,533
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
#1,755
of 3,140 holders
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 2%
Shared 0%
None 98%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MARATHON CAPITAL MANAGEMENT holds $31,900,311 across 10 Drug Manufacturers - General names. AMGN ranks #7 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
64,777 | $12,283,014 | |
| 2 | JNJ |
Johnson & Johnson
|
25,121 | $6,379,980 | |
| 3 | NVO |
Novo Nordisk A S
|
78,134 | $3,745,743 | |
| 4 | MRK |
Merck & Co., Inc.
|
23,351 | $3,000,603 | |
| 5 | LLY |
ELI LILLY & Co
|
2,492 | $2,988,979 | |
| 6 | ABBV |
AbbVie Inc.
|
6,807 | $1,712,913 | |
| 7 | AMGN |
Amgen Inc
This page
|
2,533 | $917,249 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
8,325 | $479,686 |
All Filings in AMGN
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $917,249 | 2,533 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $891,236 | 2,533 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $848,387 | 2,592 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $321,143 | 1,138 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $317,740 | 1,138 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $354,543 | 1,138 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $309,640 | 1,188 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $382,785 | 1,188 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $371,190 | 1,188 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $259,584 | 913 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $262,962 | 913 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $245,377 | 913 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $202,704 | 913 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $218,058 | 902 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $236,901 | 902 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $211,199 | 937 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $227,972 | 937 | Shares | Sole | 2022-08-12 | |
| 2021-12-31 | $210,796 | 937 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $350,021 | 1,646 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $224,250 | 920 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $222,933 | 896 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $203,479 | 885 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $235,098 | 925 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $204,018 | 865 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||